A Two-Part Study to Determine: Best Medication Formulation and Food Effect

NCT00427596 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

18

Enrollment

INDUSTRY

Sponsor class

Conditions

Overactive Bladder

Interventions

DRUG: Solabegron

Sponsor

GlaxoSmithKline